---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-105577"
form_type: "8-K"
ticker: "INCY"
cik: "0000879169"
company_name: "INCYTE CORP"
filed_at: "2022-10-04T23:59:59+00:00"
generated_at: "2026-06-23T05:46:15.321910+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Incyte elects Susanne Schaffert, former Novartis Oncology President, to board

## Summary
- Effective Oct 1, 2022, board increased to nine members, elected Susanne Schaffert.
- Dr. Schaffert spent 26 years at Novartis, most recently President of Novartis Oncology (Jan 2019–Apr 2022).
- She will serve as a non-employee director and receive standard cash/equity compensation.
- No arrangement, family relationship, or reportable transaction exists with Dr. Schaffert.
- She also serves on the board of Rubius Therapeutics, Inc.

## SEC filing metadata
- accession: 0001104659-22-105577
- form_type: 8-K
- ticker: INCY
- cik: 0000879169
- company_name: INCYTE CORP
- filed_at: 2022-10-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/879169/000110465922105577/0001104659-22-105577-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/879169/000110465922105577/tm2227007d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-105577
- JSON: https://secwatch.observer/filing/0001104659-22-105577.json
- Plain text: https://secwatch.observer/filing/0001104659-22-105577.txt

## Key facts
- Executive change
  Susanne Schaffert was elected as Director at INCYTE CORP.
  - Action: elected
  - Role: Director
  source text: Election of Directors Effective October 1, 2022, the Board of Directors of Incyte Corporation (the “Company”) increased the number of authorized members of the Board of Directors of the Company to nine and elected Susanne Schaffert, Ph.D., a member of the Board of Directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/879169/000110465922105577/0001104659-22-105577-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.